IMMUNOGEN INC 4
4 · IMMUNOGEN INC · Filed Sep 21, 2015
Insider Transaction Report
Form 4
IMMUNOGEN INCIMGN
Johnston David Brannon
Chief Financial Officer
Transactions
- Exercise/Conversion
Common stock
2015-09-17$10.79/sh+5,000$53,950→ 5,000 total - Sale
Common stock
2015-09-17$15.00/sh−5,000$75,000→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2015-09-17$10.79/sh−5,000$53,950→ 90,000 totalExercise: $10.79From: 2015-07-17Exp: 2024-07-17→ Common stock (5,000 underlying)
Footnotes (3)
- [F1]Weighted average price of shares sold
- [F2]The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan executed by the reporting person on June 16, 2015.
- [F3]Exercisable as to 33,334 shares commencing on July 17, 2015, 33,333 shares commencing on July 17, 2016, and 33,333 shares commencing on July 17, 2017.